Australian Healthcare Strong Balance Sheet Stocks

Micro-X

Market Cap: AU$31.4m

Designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa.

Singular Health Group

Market Cap: AU$107.1m

A medical technology company, engages in the development and commercialization of volumetric rendering platform (VRP) and software development in Australia.

Ansell

Market Cap: AU$4.4b

Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.

Rhythm Biosciences

Market Cap: AU$17.0m

A medical diagnostics company, provides blood tests for the detection of cancers in Australia.

Vitasora Health

Market Cap: AU$45.7m

An e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States.

Sigma Healthcare

Market Cap: AU$34.5b

Operates as a pharmaceutical wholesaler, distributor, and pharmacy franchisor in Australia and internationally.

Adherium

Market Cap: AU$5.4m

Develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.

TrivarX

Market Cap: AU$5.0m

A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.

4DMedical

Market Cap: AU$116.4m

Operates as a medical technology company in the United States and Australia.

Pro Medicus

Market Cap: AU$32.8b

A healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe.

BlinkLab

Market Cap: AU$66.0m

Focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing.

Cogstate

Market Cap: AU$293.9m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

Atomo Diagnostics

Market Cap: AU$10.7m

Engages in the development and sale of medical devices worldwide.

TALi Digital

Market Cap: AU$4.1m

A digital health company, delivers diagnostic and therapeutic solutions to enhance attention cognitive function in Australia.

Austco Healthcare

Market Cap: AU$116.5m

Operates as provider of healthcare communication solutions in Australia, New Zealand, Asia, Europe, and North America.

INOVIQ

Market Cap: AU$39.4m

Engages in the developing and commercializing of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States.

Control Bionics

Market Cap: AU$9.7m

Engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally.

Nova Eye Medical

Market Cap: AU$38.4m

Designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.

ImExHS

Market Cap: AU$15.3m

Offers cloud-based medical imaging solutions in Australia and internationally.

Microba Life Sciences

Market Cap: AU$45.3m

Provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland.

ReNerve

Market Cap: AU$17.1m

A medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures.

Artrya

Market Cap: AU$104.3m

A medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia.

Cochlear

Market Cap: AU$19.7b

Provides implantable hearing solutions for children and adults worldwide.

Nanosonics

Market Cap: AU$1.2b

Operates as an infection prevention company globally.

SomnoMed

Market Cap: AU$142.6m

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.

CleanSpace Holdings

Market Cap: AU$39.1m

Engages in the design, manufacture, and sale of respiratory protection products and services for healthcare and industrial markets worldwide.

dorsaVi

Market Cap: AU$17.3m

Engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States.

Cyclopharm

Market Cap: AU$115.6m

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally.

CardieX

Market Cap: AU$22.0m

Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.

SDI

Market Cap: AU$104.6m

Engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia, Europe, the United States, and Brazil.

Enlitic

Market Cap: AU$33.3m

Operates in the healthcare sector in the United States, Europe, and Japan.

Freedom Care Group Holdings

Market Cap: AU$4.0m

Provides care and support services to individuals with disabilities in Australia.

Resonance Health

Market Cap: AU$19.8m

A healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in Australia, the Asia Pacific, North America, Europe, the Middle East, and Africa.

Optiscan Imaging

Market Cap: AU$91.9m

Engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States.

EBR Systems

Market Cap: AU$516.5m

Develops implantable systems for wireless tissue stimulation.

Mach7 Technologies

Market Cap: AU$81.1m

Provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe, and internationally.